Drop generating device

A method of delivering safe, suitable, and repeatable dosages to a subject for topical, oral, nasal, or pulmonary use and a device for droplet ejection includes a fluid delivery system capable of delivering a defined volume of the fluid in the form of droplets having properties that afford adequate and repeatable high percentage deposition upon application. The method and device include a housing, a reservoir disposed within the housing for receiving a volume of fluid, an ejector mechanism configured to eject a stream of droplets having an average ejected droplet diameter greater than 15 microns, the stream of droplets having low entrained airflow such that the stream of droplets deposit on the eye of the subject during use.

BACKGROUND OF THE INVENTION

Using spray dispensers to administer products in the form of mists or sprays is an area with large potential for safe, easy-to-use products. The major challenge in providing such an applicator is to provide consistent and accurate delivery of suitable doses.

An important area where spray applicators are needed is in delivery of eye medications. The application of fluids, as in the case of eye drops has always posed a problem, especially for children and animals who tend to blink or jerk at the critical moment, causing the droplet to land on the eyelid, nose or other part of the face. The impact of a large drop of fluid on the eyeball, especially when the fluid is at a different temperature also tends to produce a blinking reaction. Elderly also often lose the hand coordination necessary to get the eye drops into their eyes. Stroke victims have similar difficulties. Dropper delivery often requires a particular physical position, such as tilting of the head or a horizontal position. Neither might be practical.

Often, it is critical that the subject administer the correct dose the requisite number of times per day. However, in practice, subjects that are prescribed eye medications for home use tend to forget to dose, or dose excessively or cross-dose with other medications. One of the major compliance problems is that, even if the subject is intent on following the treatment regimen, he or she often forgets to dose.

Currently, many of these medications are administered by eye droppers. Current eye drop devices often either require the head to be tilted back, the subject to lie down or provide downward traction on the lower eyelid, or a combination of traction and tilting, since the delivery mechanism typically relies on gravity for applying the medication. This is not only awkward, but involves a fair amount of coordination, flexibility and cooperation on the part of the subject to ensure that the medication gets into the eye while avoiding poking the eye with the dropper tip. Current eye dropper bottles pose the risk of poking the user in the eye, potentially causing physical damage to the eye, and further, exposing the tip to bacterial contamination due to contact with the eye. As such, the subject runs the risk of contaminating the medication in the eye drop bottle and subsequently infecting the eye. Additionally, a large volume of the medication flows out of the eye or is washed away by the tearing reflex. As a result, this method of administration is also inaccurate and wasteful. Moreover, the technology does not provide a satisfactory way of controlling the amount of medication that is dispensed, nor does it provide a way of ensuring that the medication that is dispensed actually lands on the eye and remains on the eye.

Eye droppers also provide no way of verifying compliance by a subject. Even if after a week of use the eye dropper bottle could be checked for the total volume of medication dispensed, e.g., by weighing the bottle, this does not provide a record of day-to-day compliance. A subject may have missed one or more doses and overdosed on other occasions. Also, the poor precision with which eye droppers deliver drops to the eye leaves a question mark whether the medication actually gets into the eye, even though it may have been dispensed.

Accordingly, there is a need for a delivery device that delivers safe, suitable, and repeatable dosages to a subject for ophthalmic, topical, oral, nasal, or pulmonary use.

SUMMARY OF THE INVENTION

The present invention includes a device and method of delivering safe, suitable, and repeatable dosages to a subject for ophthalmic, topical, oral, nasal, or pulmonary use. The present invention also includes a fluid delivery system capable of delivering a defined volume of the fluid in the form of droplets having properties that afford adequate and repeatable high percentage deposition upon application.

The present invention includes and provides a device for delivering a fluid to an eye of a subject, the device comprising a housing, a reservoir disposed within the housing for receiving a volume of fluid, an ejector mechanism configured to eject a stream of droplets having an average ejected droplet diameter greater than 15 microns, the stream of droplets having low entrained airflow such that the stream of droplets deposit on the eye of the subject during use.

The invention further includes and provides a device wherein the ejector mechanism comprises an ejector plate having a first surface that couples a fluid delivery area of the reservoir, the ejector plate including a plurality of openings formed through its thickness, an actuator coupled to a second surface of the ejector plate, the actuator being operable to oscillate the ejector plate at a frequency and generate a directed stream of droplets.

Yet another implementation of the invention includes and provides a device for delivering a volume of ophthalmic fluid to an eye comprising a housing, a reservoir disposed within the housing for receiving a volume of ophthalmic fluid, an ejector plate being in fluid communication with the reservoir, the ejector plate including a plurality of openings formed through its thickness, an actuator formed on a surface of the ejector plate opposite the reservoir, the actuator being operable to oscillate the ejector plate at a frequency and generate a directed stream of droplets, wherein the droplets in the directed stream have an average ejecting diameter in the range of 5-2500 microns, including but not limited to 20-100 microns, and an average initial velocity in the range of 1-100 m/s, including but not limited to, 2-20 m/s.

Yet another implementation of the invention includes and provides for a method of delivering a volume of ophthalmic fluid to an eye of a subject, the method comprising ejecting a directed stream of droplets of an ophthalmic fluid contained in a reservoir from openings of an ejector plate, the droplets in the directed stream having an average ejecting diameter in the range of 5-2500 microns, including but not limited to 20-100 microns, and an average initial velocity in the range of 1-100 m/s, including but not limited to, 2-20 m/s.

DETAILED DESCRIPTION

The present disclosure generally relates to ejection devices useful, e.g., in the delivery of fluid such as ophthalmic fluid to the eye. In certain aspects, the ejection devices include an ejection assembly which generates a controllable stream of droplets of fluid. Fluid includes without limitation, suspensions or emulsions which have viscosities in a range capable of droplet formation using an ejection mechanism.

As explained in further detail herein, in accordance with certain aspects of the present disclosure, the ejector mechanism presently disclosed may form a directed stream of droplets which may be directed toward a target. The droplets will be formed in distribution of sizes, each distribution having an average droplet size. The average droplet size may be in the range of about 15 microns to over 100 microns, greater than 20 microns to about 100 microns, about 20 microns to about 80 microns, about 25 microns to about 75 microns, about 30 microns to about 60 microns, about 35 microns to about 55 microns, etc. However, the average droplet size may be as large as 2500 microns, depending on the intended application. Further, the droplets may have an average initial velocity of about 0.5 m/s to about 100 m/s, e.g., about 0.5 m/s to about 20, e.g., 0.5 to 10 m/s, about 1 m/s to about 5 m/s, about 1 m/s to about 4 m/s, about 2 m/s, etc. As used herein, the ejecting size and the initial velocity are the size and initial velocity of the droplets when the droplets leave the ejector plate. The stream of droplets directed at a target will result in deposition of a percentage of the mass of the droplets including their composition onto the desired location.

Fluids suitable for use by the ejection device can have very low viscosities, e.g., as with water at 1 cP, or less, e.g. 0.3 cP. The fluid may additionally have viscosities in ranges up to 600 cP. More particularly, the fluid may have a viscosity range of about 0.3 to 100 cP, 0.3 to 50 cP, 0.3 to 30 cP, 1 cP to 53 cP, etc. In some implementations, solutions or medications having the suitable viscosities and surface tensions can be directly used in the reservoir without modification. In other implementations, additional materials may be added to adjust the fluid parameter.

The disclosed technology includes ejected droplets without substantial evaporation, entrainment of air, or deflection off of the eye surface, which facilitates consistent dosing. Average ejecting droplet size and average initial velocity are dependent on factors including fluid viscosity, surface tension, ejector plate properties, geometry, and dimensions, as well as operating parameters of the ejector mechanism including its drive frequency. In some implementations, about 60% to about 100%, about 65% to about 100%, about 75% to about 100%, about 80% to about 100%, about 85 to about 100%, about 90% to about 100%, about 95% to about 100%, etc., of the ejected mass of droplets are deposited on the surface of the eye, such deposition being repeatable. The direction of flow of the stream of droplets may be horizontal, or any direction a user chooses to aim the actuation mechanism during use.

Without wishing to be bound by this theory, it is believed that as droplet diameter decreases, the ratio of the total surface area to total volume increases. That is, more surface area is exposed for a given total volume of fluid. Therefore, smaller droplets may create a larger surface area which creates more drag. In the low Reynolds number regime (Re<1), the drag force is given by Stoke's law, a solution to the Navier-Stokes equations. Thus, the drag force is believed to be proportional to the square root of the surface area of a droplet. Presuming that the droplet is spherical, the drag force is believed to be proportion to the diameter of the droplet.

Each particle carries air along with it (entrained air), creating an airstream. This effect of this entrained air stream is believed to be approximately proportional to diameter. When the airstream reaches a target, it may deflect or sharply turn, say by 90 degrees adjacent to the surface of the target to maintain flow. If the flow of the airstream is too large, it may carry some of the droplets with it, causing them to deflect and not deposit on the surface of the target. Particles with sufficiently large momentum will overcome this effect and successfully deposit on the surface. The stopping distance is an approximation of the distance the particle will travel before the initial momentum is diminished to zero by air friction. Entrained air created by surrounding particles will increase the stopping distance, giving each droplet a larger possible range and more opportunity for deflection. Droplets also fall vertically during their flight path due to gravity. After a short acceleration time, droplets reach their terminal velocity where the drag force is equal and opposite to the gravitational force. Larger particles fall faster because terminal velocity is proportional to their surface area. The droplet lifetime also depends on the local and ambient partial pressures, the local and ambient temperatures, and the particle diameter, all of which affect its rate of evaporation. Generally, larger particles will evaporate slower.

Again not limited by any particular theory, droplets are formed by an actuation mechanism that forms the stream of droplets from fluid contained in a reservoir coupled to the ejector mechanism. The ejector mechanism and reservoir may be disposable or reusable. They may be packaged in a housing. The housing may be disposable or reusable. The housing may be handheld, miniaturized, formed to couple to a base, and may be adapted for communication with other devices. Housings may be color-coded or configured for easy identification. Droplet ejector devices, in some implementations, may include illumination means, alignment means, temperature control means, diagnostic means, or other features. Other implementations may be part of a larger network of interconnected and interacting devices used for subject care and treatment. The ejector in one implementation may be a thermal ejector. In another, it may be an ultrasonic ejector. In yet another implementation, the ejector may be a piezoelectric ejector.

FIGS. 18A-Cshows the stopping distances in still air of the droplet having different droplet diameters and at ejecting velocities of 0.5 m/s, 1 m/s, and 2 m/s, respectively. In particular, referring toFIG. 18A, in this implementation, the longest stopping distance of a droplet having an ejecting diameter of 100 microns or smaller and an initial velocity of 0.5 m/s is about 1.25 cm. Accordingly, in this implementation, without assistance from an airflow, these droplets cannot be effectively deposited into an eye located more than 1.25 cm away from the ejector plate102. Referring toFIG. 18B, the longest stopping distance of a droplet having an ejecting diameter of 100 microns or smaller and an ejecting velocity of 1 m/s is about 2.2 cm. Accordingly, in this aspect, without assistance from an airflow, these droplets cannot be effectively deposited into an eye located more than 2.2 cm away from the ejector plate1902(FIG. 19A). Referring toFIG. 18C, the longest stopping distance of a droplet having an ejecting diameter of 100 microns or smaller and an ejecting velocity of 2 m/s is about 4 cm. Accordingly, without assistance from an airflow, these droplets cannot be effectively deposited into an eye located more than 4 cm away from the ejector mechanism. The stopping distances of fluids containing ingredients other than water may be different from those shown inFIGS. 18A-C.

Before reaching the target, the ejected droplets may evaporate in the air. Delivering droplets having an ejecting velocity of about 1 m/s to about 5 m/s to a target located about 3 cm from the ejector mechanism may take about 0.03 s or less to reach the surface of the target. Without wishing to be bound by this theory, it is believed that the rate of evaporation is related to the diameter of the droplets and the environmental parameters including temperature and humidity. It is also believed that a long evaporation time, e.g., longer than the delivery time of about 0.03 s, is desired for effectively depositing the droplets. Assuming that the temperature is 20° C. and the fluid is water,FIG. 18Dshows that the a droplet having a diameter of about 40 microns completely evaporates in about 1 s, and a droplet having a diameter of about 100 microns completely evaporates in about 10 s. In some implementations, saline or other additives can be added into the fluid to reduce the evaporation rate.

FIGS. 19A-Fshow deflection of the droplets and entrained airstream against a target. Droplets without sufficient momentum to counterbalance the forces from this stream are carried by it and are similarly deflected. Nevertheless, those droplets having a sufficient momentum, either due to high velocity or high mass or both, do continue on their own trajectory and are not carried away by the airstream. These droplets can be effectively delivered to the target. Sufficient momentum can be achieved from a large initial ejecting velocity and a momentum to drag ratio. Velocity, however, must not create discomfort when the droplets impact the target, should the target be for human or animal use, and should not be such as to adversely affect other parameters such as drag. Alternatively, sufficient momentum can be achieved by an increase in the mass of the droplet.

Referring toFIGS. 19A-F, in this implementation, water droplets1912having different average ejecting diameters are ejected at an ejecting velocity of 4 m/s from an ejector plate1902horizontally towards a surface1916located 3 cm away from the ejector plate1902. The surface1916can be a glass surface that has features, e.g., smoothness, similar to an eye surface. Other than the diameter of the openings (e.g., like the openings1626ofFIG. 16A) in the ejector plate1902, all other parameters, are kept the same in all ofFIGS. 19A-F.

Referring toFIG. 19A, in that implementation, the ejected droplets1912have an average ejecting diameter of about 11 microns. The stream1014aof the droplets1912has a varying cross-sectional area, indicating that some of the droplets1912may have stopped before reaching the surface1916. Furthermore, a substantial amount1918aof droplets1912reaching the surface1916is carried away by air along the surface1916without being deposited onto the surface.

Referring toFIG. 19B, in this implementation, the ejected droplets have an average ejecting diameter of about 17 microns. The stream1914bof the droplets1912also has a varying cross-sectional area (like the stream1914a), indicating that some of the droplets may have stopped before reaching the surface1916. However, the cross-sectional area variation of the stream1914bis smaller than the variation of the stream1914a. As a result, more droplets1912in the stream1914breach the surface1916than in the stream1914a. However, a substantial amount1918bof droplets1912reaching the surface1916is carried away by air along the surface1916without being deposited onto the surface1916. The amount1918bis larger than the amount418aso that although a larger amount of droplets1912reach the surface1916, the deposited amount on the surface1916does not increase substantially compared toFIG. 19A.

Referring toFIG. 19C, the ejected droplets have an average ejecting diameter of about 32 microns. The stream1914cof the droplets1912has a cross-sectional area that varies substantially less than those of the streams1914a,1914b, indicating very few droplets may have stopped before reaching the surface1916. Furthermore, an amount1918cof droplets1912reaching the surface1916and carried away by air along the surface1916without being deposited onto the surface1916is smaller than the amounts1918a,1918b.

Referring toFIGS. 19D-19E, in this implementation, the ejected droplets have average diameters of about 56 microns, 100 microns, respectively.FIG. 19Fshows ejection of large droplets. The streams1914d,1914e,1914fof the droplets1912have substantially constant cross-sectional area, indicating that substantially no droplets have stopped before reaching the surface1916. Furthermore, substantially no droplets1912reaching the surface1916are carried away along the surface1916without being deposited onto the surface.

In summary, the calculations inFIGS. 18A-Dand the photographs inFIGS. 19A-Fsuggest that airstream can have undesirable effect of carrying droplets across the target surface by movement of the entrained airstream and thereby prevent them from depositing on the target. Furthermore, this undesirable effect is most pronounced for smaller droplets. Without wishing to be bound by this theory, it is believed that this problem occurs with small droplets for a number of reasons more fully described below.

Additionally, charging the droplets may improve their ability to reach the target. The human body, and especially the moist eye surface, is a conductor, therefore it may attract the charged droplets aiding in their contact with the target. While wishing not to be limited by this theory, the charged droplets form a space charge cloud while in transit to the target. This space charge creates an electric field E which repels the similarly charged droplets to the target by the Coulomb force. When a drop gets close to the target, the electric field from the charged droplet creates an equal and opposite image charge in the conductive target which attracts the droplet.

Several methods for charging droplets are known. Tribocharging (frictional) charging, applying a voltage to the ejector plate and charges the droplets by induction, and charging by high voltage corona discharge to generate gas ions and charge the droplets by Pauthenier field charging and/or diffusion charging are three such examples. In tribocharging the fluid is passed through small orifices, e.g., of a ejector plate or grid, which results in charging. The effect can be enhanced by coating the ejector plate or grid.

The droplet ejecting device includes ejection mechanism. In some implementations, the mechanism includes an ejection plate or substrate. In some implementations, this is coupled to a fluid reservoir, examples of which are discussed herein. One implementation of the ejector mechanism may be a thermal ejector (or “bubble jet”). The implementation ofFIG. 1shows a substrate structure100with multiple openings102formed into the substrate structure. This can be achieved by any one of a number of known techniques. This substrate can be formed into a microelectromechanical system (MEMS). Bulk micromachining is one of the known technique for forming silicon based MEMS. The MEMS may be formed on a substrate structure, e.g., a silicon substrate. MEMS can be formed in a similar manner to a semiconductor package. Alternatively, the mechanical and electronic components can be formed separately and be subsequently bonded to one another.

In the implementation shown inFIG. 1only 12 openings are shown for illustrative purposes. However, several hundreds or even many thousands of openings may be formed on a substrate that is, by way of example, 0.5 cm×0.5 cm in surface area. In this implementation the substrate structure is shown upside down with its distal surface104and its proximal surface106. As shown in the implementation ofFIG. 1, each of the openings102is provided with a heating element108surrounding the opening on the distal surface104. Thus the MEMS device defines a disk-like substrate structure with multiple channels defined by the openings102extending in this implementation from the distal to the proximal surface as shown inFIG. 2. The heating elements108, in this implementation, are shown at the bottom of the channels on the distal surface. Intervening substrate material, referred to herein as streets110, are formed between the channels102.

In one implementation the openings may be formed in the substrate have a radius of 37 microns and a substrate thickness of 74 microns with intervening streets of 12 microns for a center-to-center distance of 86 microns. Assuming spherical drops are emitted from each of the openings the volume of material in each opening will be πr2×t=π(372×74)×10−18=3.18×10−13m3=318 pico liter. The amount of area (opening and surrounding street area) for each unit or opening is thus (37+12+37)2μm2=7.396×10−9m2. Thus in a substrate of 0.5 cm×0.5 cm=0.25×10−4m2this provides for a total of 3380 openings for a total fluid volume in the openings of approximately 1 μl.

In the above implementation a opening size of 74 microns was selected, which provides for rather large drops of fluid. It will be appreciated that the size of opening chosen will depend on the viscosity of the chemical. The duty cycle or rate of firing of the openings also depends on the volume flow that is desired and will depend on the application. In one implementation droplet sizes of the order of 300 pL may be ejected from the ejector fabricated from a substrate with ratio of opening diameter to substrate thickness of 10:1 to 1:10.

In some implementations the use of materials having a higher operating temperature and lower coefficient of thermal expansion and also provide higher thermal conductivity and lower heat capacity for rapid cooling and improved duty cycle control can be utilized. The material preferably also has a high thermal shock parameter, as is provided for example by silicon carbide (SiC) or any of its poly types (different atomic arrangements). In the present implementation the substrate may made from silicon carbide having a 6H crystal lattice configuration.

As mentioned above, while SiC always involves a combination of silicon and carbon, the crystal lattice structure may vary and includes structures such as 3C (cubic) atomic arrangements with the atoms located at the corners of cubes forming a lattice structure, or a hexagonal (4H or 6H) arrangement that repeats every four or six layers or a rhombohedral arrangement. A comparison of the arrangements and properties of 3C, 4H and 6 H are given in the table below. Such properties may provide guidance for the selection of appropriate substrate material.

As discussed above in this implementation, the substrate is coupled to a reservoir.FIG. 3A, the substrate material300with its openings302is secured to a substrate having a central cavity306etched into it to define a housing304which, in this implementation is also made of silicon carbide and defines a chamber306between the substrate material300and the housing304. The chamber306, in its operative state is filled with the fluid to be dispensed. It will be appreciated that more than one housing may be secured to the substrate material300, thereby allowing some openings in the substrate material300to be in flow communication with the fluid in one chamber while other openings are in flow communication with another fluid. This allows fluids to be mixed by firing a selected number of openings from each group. As shown inFIG. 3A, an inlet channel310is formed in a wall of the housing304to provide fluid communication with a fluid source to replenish the chamber in the housing304.

FIG. 3Bshow an alternative implementation of the invention. In this implementation, more than one medication may be ejected from the thermal ejector, e.g., by providing the ejector with multiple holes and providing some of the holes with a first medication and other holes with a second medication, or by providing multiple reservoirs, each feeding a different set of holes, as is depicted inFIG. 3B, which shows a disposable reservoir unit700that, in this implementation, comprises 4 reservoirs702, which are secured to a substrate structure710(shown here prior to attachment to the reservoirs). The controller may be configured to control which holes to fire and the number of times each hole is to be fired in succession, thereby allowing different dosages of the various medications to be provided, either simultaneously, or at different times.

In order to eject fluid droplets from the openings the substrate the heating elements such as the elements108shown inFIGS. 1 and 2are rapidly heated to vaporize the intervening fluid, within the heating element loop to pinch off the fluid in the channel and effectively shooting the fluid droplets out of the opening through the force generated by the fluid vapor. It will be appreciated that droplet size and speed will vary depending on many factors including fluid viscosity, surface tension, ejector plate properties, geometry, and dimensions, as well as operating parameters of the ejector including its duty cycle or drive frequency. By way of example, for opening diameters and length of 5 microns, 15 microns, and 38 μm, the volumes of the droplets are 0.1 picoliter (one millionth of a microliter), 2.7 picoliter and 44 picoliters, respectively.

As mentioned above, the present invention makes use of a substrate material such as SiC, which has a high operating temperature to withstand the high heating of the fluid being ejected, a low coefficient of thermal expansion (meaning that as the temperature changes the material remain pretty constant in size), provides high thermal conductivity (thereby allowing rapid dissipation of heat between heating cycles to allow accurate control of the duty cycle), a low heat capacity, and a high thermal shock parameter. The parameters of the material allow it to rapidly heat the fluid, causing the disk of fluid in the openings that is surrounded by the heating element to heat very quickly to its boiling point, thereby explosively propelling the fluid droplet above the vapor disk from the proximal end of the opening. Other suitable substrate material such as silicon can be used.

In one implementation, an electrical circuit heats the fluid and affects the droplet ejection process. An implementation of this circuit is shown inFIG. 4. An electric power source in the form of a battery400or voltage generator is connected in parallel with the heating elements404. Controllable switches406in this implementation takes the form of relays that include a solenoids408controlled by a processor410. WhileFIG. 4shows only two resistive elements404and two switches406controlled by the processor410, it will be appreciated that the processor410preferably controls each of the heating elements formed around the substrate openings. Thus the processor can control which openings and how many openings to fire and how many times per second to do so in order to achieve a desired fluid volume. While this implementation made use of heating elements formed around the openings, other implementations make use of other heating element configurations, e.g., plates mounted inside, above, or below openings inlet pipes (through which the fluid in the hole is replenished).

One benefit of the implementation is that it provides the ability to accurately control droplet ejections by controlling openings to fire and the selection of the number of openings to be fired. It also allows two or more medications to be mixed at time of ejection by providing different sets of openings with different reservoirs filled with different medications. The ratios of two or more medications can be accurately controlled by determining the number of openings to fire from each set or by adjusting the duty cycles for each set. The small droplet size of the medications emitted from the substrate material also ensures thorough mixing of the medications as they are emitted.

One implementation of the droplet ejection device is shown inFIG. 5. It shows a substrate structure500of a thermal ejector implemented as a MEMS device and housed in a housing502. The housing502includes a hand-actuated trigger504, an eye-sensor506in the form of a CCD array or near infrared (NIR) sensor to detect an eyeball or the retina of the eye, a light source508(in this case a focused LED providing a low intensity light substantially along the ejection path of the thermally ejected fluid droplets), and a reservoir514which in this case is releasably attached to the housing502and is in flow communication with the holes in the substrate structure500. The reservoirs can be refillable, allowing the rest of the applicator to be refillable.

FIG. 6shows a processor600is mounted on a circuit board inside the housing502and controls the flow of current through an electrical circuit from a power source602(implemented in this implementation by a battery) to the heating elements604of the thermal ejector. In this implementation the electrical circuit includes three switches connected in series as shown by the circuit inFIG. 6. The first switch610is controlled by the hand-actuated trigger604. The second switch612is controlled by the processor600in response to signals provided by the eye-sensor506. The circuit also includes a second heating element620, a Peltier cooler622that are selectively activated based on signals provided to the processor600by a temperature sensor624. In response the processor600closes the switch630or632to either heat or cool the fluid in the holes of the substrate structure. Other suitable circuits may be substituted for that shown inFIG. 6.

Another implementation of the invention is shown inFIG. 7, which shows a three dimensional view of contact lens solution dispenser of the invention. In this implementation the fluid is dispensed using a thermal ejector700. A cover702is shown in its retracted position but is movable to a closed position by sliding the cover702upward so as to cover the thermal ejector700. A button704, which can be thumb-activated, controls the dispensing of the fluid. This implementation may also be implemented as a disposable device, as well as portions of it may be disposable. For example, a replaceable reservoir or cartridge can be used. In practice a user may attach the reservoir512to the housing e.g., if the reservoir is disposable and requires replacement.

The device can be pointed at the target, for example, an human or animal eye, using an LED, e.g. LED708, to help in correctly aligning the applicator. Once the eye-sensor, e.g., sensor506, detects an eye, it sends a signal to the processor600, which closes the second switch612, which is implemented as a relay in this implementation, to allow current to pass from the power source to the heating elements of the thermal ejector. One implementation of the device which could be embodied in any of the implementations may include an ejector assembly and LED that turns on when the device is switched on, for example, by a power switch or lifting the device out of a docking station. The light from the LED is shone onto the target, e.g., the subject's eye to correctly target the eye prior to dispensing fluid. The device may include a rest, support, or spacer to aid in alignment as discussed below.

Other implementations to ensure correct alignment of the device with the eye are also contemplated. These implementations, examples of which are shown inFIGS. 8-13Bmay be formed as handheld or palmheld units and can be miniaturized to the a further extent for additional applications. In one implementation, shown inFIGS. 8 and 9a mirror800is provided on the housing for reflecting an image of the user's eye back into the user's eye when the device is correctly aligned with the eye. In this implementation a cross-hair is provided on the mirror, as shown in the front view ofFIG. 9, to help the user centralize the device for ejection of fluid into the eye. The implementation ofFIGS. 1 and 2also includes an LED810to alert the user when a dose is due and a second LED812to light up when a full dose has been delivered.

FIG. 9shows another implementation. An infra-red transmitter800(e.g., IR LED) and infrared (IR) photo detector901are mounted on the front surface of the device to transmit an infra red beam or pulse, which is received by an IR photo detector902when the device is correctly aligned with the eye and the IR beam or pulse is reflected off the eye.

Yet another implementation of the invention is shown inFIG. 10, which makes use of a conical sleeve1000to position the eye relative to the thermal ejector. The sleeve1000can, for example, be implemented as a rubber or silicon hood, and may serve the additional function of providing a shaded or darkened imaging zone for imaging the eye with a scanner or camera. A button1002is mounted on the device for triggering the ejection of the fluid, and a second button1004serves to trigger an image capturing device (not shown) mounted on the device under the sleeve1000.

FIG. 11shows another implementation a low intensity light beam e.g., light emitting diode (LED)1100emits a beam when button1102is depressed. The light beam is configured to shine into the user's eye when the thermal ejector1106or other fluid dispenser of the device is correctly aligned with the eye, as shown by the implementation ofFIG. 11. This implementation does not have a camera for capturing an image of the eye, but serves simply to dispense fluid, e.g., a flushing fluid or medication into the eye by depressing a button or switch1104. The button1104, in the case of a thermal ejector closes a switch to heat the heating elements of the thermal ejector or sends a signal to a controller for controlling one or more heating elements of the ejector as is described in greater detail below.

InFIG. 12, an image capture device, including cameras, scanners, or other sensors without limitation, e.g. charge coupled device (CCD),1200, may provided to detect the presence of an eye and to ensure that the eye is open. The eye sensor provides control information, which in one implementation provides a controlling signal to a controller or processor in the device for controlling the ejection of fluid. Thus, a processor is included in such implementations to control the activation of the ejector mechanism to eject fluids only when the camera image indicates that the eye or a pre-defined area of the eye is correctly aligned with the fluid applicator. Thus, for example, with a thermal ejector, only the holes that are correctly aligned with the eye may eject fluid. The device can readily take into account the delay between the signal from the camera and the ejection of droplets from the device and can time delivery to beat the blink cycle.

Implementations of the device provides numerous benefits over other devices for many reasons. For example, not only does it ensure that the fluid that is dispensed is dispensed into the eye by allowing the device to be correctly aligned, the device is capable of dispensing at speeds that ensure beating the blink of an eye. Using a thermal ejector based system in accordance with the invention and integrating it with an optical camera or other eye detector or eye sensor, to provide feedback to the device ensures that the eyelid is open and that the eye is correctly aligned with the thermal ejector. Only when the eye is determined to be open will the applicator of the invention dispense a carefully measured dose of medication or vaccine in the form of a fine mist directly into the eye. The sub-second response time, is particularly useful for people or animals who are sensitive to anything coming close to their eye by ensuring that the speed of delivery is able to “beat the blink”. Other benefits of the device include delivering quantifiable and repeatable results by selectively dispensing a precisely controllable volume of fluid such as a medication or vaccine.

Different implementations as understood and disclosed permit a user to turn on the device. A user may simply lift the device off of a base which then activates or turns on the device. The user can also turn on the device by depressing a trigger, such as trigger504. In some implementations, where the ejector mechanism is thermal or ultrasonic, engaging the trigger or turning on the device, commences to heat or cool the device or portions thereof to a predetermined temperature. For example, the device may be heated or cooled to the body temperature of a human or animal.

After the device is turned on, the ejection mechanism can be triggered. In the implementation ofFIGS. 8 and 9, activation trigger802serves as the triggering mechanism to fire the holes of the actuation mechanism, subject to control by a controller in the device that monitors the amount of fluid that needs to be dispensed and the amount of fluid that has already been dispensed. Of course, the button can be any suitable means to turn on a device including electrical and mechanical activation triggers, pushbuttons, levers, slide switches, tactile switches including momentary switches, pressure pads, motion sensors, magnetic and Hall effect switches, electrostatic switches, resistive or capacitive touch switches, Reeves switches, switches operated by infra-red, radio frequency, light, or sound detectors, or timers or internal activation signals. The activation may be local or remotely controlled.

Some implementations may include a watchdog timer which monitors the device to ensure proper operation. In another implementation, the device may sense the presence of the droplet steam for self-diagnostic purposes and to confirm proper operation. By way of example, one or more light emitters, e.g., LED, laser diode, may be used to shine light against the droplet stream. In one implementation, the light may be shown perpendicularly to the stream. A device may include, in one implementation, light detectors, e.g., photo detector, which may be used in conjunction with a shone light to detect reflection and refraction, such as reflection of the shone light off of the stream, and use this detection to determine proper operation of the device. A system may further react in response to the detection and determination of proper operation, e.g., by alerting a compliance agent or system that the device may not be properly functioning.

In the implementation ofFIG. 12, the device also includes a hand operated trigger1202, however, in this implementation the ejection is subject to correct positioning of the ejector mechanism1210relative to the eye as defined by the image information obtained from the camera1200.

The illumination mechanism, such as the LED explained above, may be in ranges above 280 nm, including, e.g., 290-1600 nm, wavelengths for illuminating the target. The illumination mechanism may be operable to pulse the light for different periods of time, e.g., 120 ns to limit pupil reaction and permit analysis of the eye with different frequency optical detectors, scanners, or cameras as explained above. Furthermore, the device may include an adaptive optics chip to perform wavefront correction for clearer images. The device may also include a fixation source e.g., an LED or LED pattern to define a moving eye-focusing image and assist with pediatric usage. This also serves to move or rotate the eyeball during application of medication to assist in spreading the medication across the corneal surface.

Features of the devices can be formed in alternative implementation. The following are a few examples.FIGS. 13A and 13Bshow another implementation of the invention. The device shown inFIG. 13B, the ejector includes a removable reservoir1300, which allows both the reservoir and ejector to be discarded once the fluid in the reservoir is depleted. This helps to maintain a sterile dispensing area and avoids excessive build-up of dust and dirt on the thermal ejector. Also,FIGS. 13A and 13Bdepict a cover which is hinged in these implementations. Cover1301flips down to provide a cover for the ejector. This protects the ejector mechanism when not in use or in transport. Also, by engaging with a peripheral seal1302, the cover1301reduces evaporation of fluid. Cover1301can also be used as a spacer or rest to rest against, for example, the eyebrow, to align the device against the target, for example the eye.

The cover may also hinge up as shown inFIGS. 14A and 14B. A spacer may also be formed as a separate or integral piece on the exterior of the device as depicted by1500inFIG. 15A. The spacer rests against a portion of the anatomy to aid in alignment of the device with the target. In addition to the noted covers, the cover may be omitted. Additionally, the cover can be of any suitable mechanism, including iris-type closure, covers that slide from left to right, cover that are coupled via a friction fit, in a threaded manner, louvered, or clipped on. The cover can be coupled with any suitable mechanical, magnetic, or electromechanical means. For disposable packages, the cover may be an exterior or protective wrapping or covering. Additionally, the cover may be sealed against the ejection area with a leaf spring or other polymeric seal. This seal can be made of a suitable polymer, for example, polypropylene, polyethylene, high density polyethylene or teflon. Furthermore, other seals such as ceramic sealers, metallic sealers, or gaskets can be used to seal the cover against the housing.FIG. 15B-Hshow several alternative implementations of covers.

In some instances, it may be desirable to control the temperature of the fluid in the device outside of the ejection cycle. In these implementations, the device may include a cooler, e.g., a Peltier device, for keeping the fluid cool where needed. The device may also include a heater for warming the fluid to a predefined temperature, e.g., the eye surface temperature of the person to whom the fluid is to be administered. The temperature range may be controlled by the controller.

In addition to the thermal and ultrasonic ejector mechanism, the ejector mechanism may be piezoelectric. Referring toFIG. 16A, an assembly1600may include an ejector mechanism1601and reservoir1620. The ejector mechanism1601may include an ejector plate1602that can be activated to vibrate and deliver a fluid1610, contained in a reservoir1620, in the form of ejected droplets1612along a direction1614. In the example ofFIG. 16A, the fluid may again be an ophthalmic fluid that is ejected towards an eye1616of a human adult, child, or animal. Additionally, the fluid may contain an active pharmaceutical to treat a discomfort, condition, or disease of a human or an animal.

Referring toFIGS. 16A-16C, the ejector plate1602as shown has a circular shape with two opposite surfaces1622,1625. Although not shown, the ejector plate can also have other shapes, e.g., an oval, square, or generally polygonal shape. Additionally, the ejector plate need not be flat. The plate may include a surface curvature making it concave or convex. The ejector plate may be a perforated plate that contains at least one opening1626. The opening or openings1626form the droplets as fluid1610is passed through. The ejector plate1602may include any suitable configuration of openings, one configuration being depicted inFIGS. 16A,16B, and16F. The openings may be formed in an ejector plate, a grid, a spiral, rectangular, rectilinear, or other pattern. The pattern may be regular or irregular. The pattern may maintain a uniform spacing of openings, or the spacing may be varied. For example, the density of openings may increase or decrease towards the center of the plate. The pattern may also cover all or part of the plate. These patterns are not limited to piezoelectric ejection devices and may be used in conjunction with the other types of ejection mechanisms, including thermal and ultrasonic. A more detailed discussion of the pattern and the region1632containing openings1626appears below.

Additionally, the openings1626may be formed in any suitable shape or volume with an appropriate aspect ratio. One example is shown inFIG. 16A.FIG. 16Ashows openings having a cylindrical shape, that is, the diameter of the opening extending from surface1622to1625remains generally constant. Nevertheless, the openings need not be limited to this cylindrical shape and may be tapered or conical. The tapered may extend the entire thickness from surface1622to1625, or it may extend part way. The opening may also be beveled on one or both sides. The bevel may be have an angled edge or a curved edge. The cross section of the opening may be round as shown inFIG. 16For may have any other suitable shape. A few examples may be round, oval, rectangular or polygonal. The openings may be regularly shaped or irregularly shaped. The shape may be symmetric or asymmetric. The size and shape of the openings1626affects the size and shape of the droplets and the droplet stream created by the ejection mechanism1601. It may also affect the density distribution throughout the droplet stream. Thus, the size and shape of the openings as well as their pattern is selected to produce the desired properties of the droplet stream in accordance with the principles and teachings of the present disclosure. The properties of the droplet stream affect delivery of the fluid and the dosage of any therapeutic or active ingredient. The properties of the stream also affect the subjects' comfort. For example, a stream which delivers too much force would induce pain or discomfort. Such a stream may also induce tearing or blinking which in turn may reduce the amount of fluid effectively delivered to the subject. In contrast, an appropriately formulated stream will have little to no discomfort and will not induce blinking or tearing. A few examples of different shapes for the openings are shown inFIGS. 16L-16R. These shapes are not limited to piezoelectric ejection devices and may be used in conjunction with the other types of ejection mechanisms, including thermal and ultrasonic.

Ejector plate1602is coupled to an ejector which activates the plate to form the droplets upon activation. The manner and location of attachment of the ejector1604to the plate1602affects the operation of the ejection assembly and the creation of the droplet stream. In the implementation ofFIG. 16B, the ejector1604is coupled to a peripheral region of surface1622of plate1602. Center region1630is not covered by the piezoelectric ejector1604. Region1632of ejector plate1602contains a central region1630which contains one or more openings1626. The fluid1610is passed through openings1626to form droplets1612. The piezoelectric ejector1604may be of any suitable shape or material. For example, the ejector may have an oval, a square, or a generally polygonal shape. The ejector1604may conform to the shape of the ejector plate1602, or regions1630/1632. Alternatively, the ejector1604may have a different shape. Furthermore, the ejector1604may be coupled to the plate1602or surface1622in one or more sections. In the example shown inFIG. 16B, the piezoelectric ejector1604is illustrated in the shape of a ring. that is concentric to the regions1630and1632. The openings1626may be located in ejection region1632. Region1632may occupy a portion of region1630, as shown inFIG. 16B, or may occupy the entire area of region1630(not shown). The portion of region1630occupied by region1632may be in the center of region1632or it may be offset from the center (not shown). In some implementations, for example as depicted inFIGS. 16A and 16E, the size of the region1638of the reservoir housing1608corresponds substantially to the size of ejection region1632. In some implementations, the open region1638may be substantially larger than the ejection region1632.

As with the size and shape of the openings1626, the size and shape of the ejection region1632can be selected based on the desired properties of the droplet stream. As shown inFIG. 16F, by way of example, the openings1626are arranged in a circular pattern in the ejection region1632of the ejector plate1602, but other patterns may also be used as explained above. The distance l between adjacent openings126may be any suitable value, including, 1 microns to a few mm, e.g., 150 microns to 300 microns. In one particular implementation, l is chosen to be 200 microns. Additionally, also as explained above, the separation of the openings1626need not be uniform.

FIG. 16D, depicts ejector plate1602disposed over reservoir housing1608which contains fluid1610. Surface1625of plate1602is adjacent to the fluid1610. Reservoir1608has open region1638as shown inFIG. 16Ewhich is adjacent to surface1625and to the region1632of plate1602. In this implementation, surface1625encloses the fluid1610in the reservoir1608. The reservoir housing1608can be coupled to the ejector plate1602at a peripheral region1646of the surface1625using a suitable seal or coupling. By way of example,FIG. 16Eshows O-ring1648a. Although not shown, more than one O-ring can be used. As known in the art, the O-rings may have any suitable cross-sectional shape. Furthermore, other couplers such as polymeric, ceramic, or metallic seals can be used to couple housing1608to the ejector plate1602. Alternatively, the coupling can be eliminated altogether and the housing1608can be integrally connected to plate1602, for example by welding or over molding. In such an implementation, an opening through which fluid is supplied to reservoir housing1608may be provided. Further still, the couplings may be made removable, such as a hinge, or may be made flexible or nonrigid connector, e.g., polymeric connector. When the housing1608is coupled to the ejector plate and fluid1610is contained within the reservoir, the fluid1610does not leak between use cycles-even if the openings1626are exposed to the exterior. This is due to the surface tension of the fluid1610given the size scale of the openings. The peripheral region1646can at least partially overlap with the peripheral region1624and can extend beyond the peripheral region1624, although such overlap is not required. The contact in which the reservoir housing1608and the ejector plate1602are coupled to each other is relatively small so that the attachment of the reservoir housing1608to plate1602does not substantially affect the vibration of the ejector plate1602when the ejector plate is activated.

Other than the open region1638, portions of the ejector plate1602may be covered by an additional reservoir wall1650. In the implementation ofFIG. 16E, wall1650does not directly contact the ejector plate1602, rather it is coupled to O-rings1648a. Alternatively, wall1650can be directly attached to plate1602. Furthermore, housing1608can be directly attached to plate1602and wall1650can be omitted altogether.

As the ejection assembly1600is used for delivering therapeutic agents or other fluids to eyes, the ejection assembly1600is designed to prevent the fluid1610contained in the reservoir1620and the ejected droplets1612from being contaminated. In some implementations, for example, as shown inFIG. 16C, a coating160can be formed over the exposed surface of the piezoelectric ejector1604and at least a part of the surface1622of the ejector plate1602. The coating may be used to prevent direct contact of the piezoelectric ejector1604and the electrodes1606aand1606bwith the fluid1610. The coating may be used to prevent interaction of the plate or ejector with the fluid or it may be used to protect the piezoelectric ejector1604and electrodes1606aand1606bfrom the environment. For example, the coating can be a conformal coating include a nonreactive material, e.g., polymers including polypropylene, nylon, or high density polyethylene (HDPE), gold, platinum, or palladium, or coatings such as Teflon®.

Referring toFIG. 16G, in some implementations, the ejector plate1602can be coated with a protective coating1662that is anti-contamination and/or anti-microbial. The protective coating1662can be conformal over all surfaces of the ejector plate1602, including surfaces1664defining the openings1626(only one opening shown). In other implementations, the protective coating1662can be applied over selected surfaces, e.g., the surfaces1622,1625, or surface regions, e.g., parts of the surfaces1622,1625,1664. The protective coating can be formed of a biocompatible metal, e.g., gold, iridium, rhodium, platinum, palladiums or alloys thereof, or a biocompatible polymer, e.g., polypropylene, HDPE, or Teflon®. Antimicrobial materials include metals such as silver or polymers such as polyketones. The protective coating can be in direct contact with the fluid1610or the droplets1612. The coating may provide an inert barrier around the fluid or may inhibit microbial growth and sanitize the fluid1610and/or the droplets1612.

Additionally, surface1622of plate1602, e.g.FIGS. 16A and 16E, may also be coated. The coating may be a hydrophilic or hydrophobic coating. Additionally, the coating may be coated with a protective later. The surface may also be coated with a reflective layer. A coating layer may be both protective and reflective. Alternatively, the surface may have been formed to be reflective. For example, the surface may be made of stainless, nickel-cobalt, or other reflective material. A surface may have been formed or polished to be reflective. In addition to making the surface1622reflective, the surface may also be backlit on its surface or around its perimeter and shown inFIG. 26. In ophthalmic applications, a reflective surface aids the user in aligning the ejector assembly with the eye.

In some implementations, the ejector plate1602can itself be formed of a metal, e.g., stainless steel, nickel, cobalt, titanium, iridium, platinum, or palladium or alloys thereof. Alternatively, the plate can be formed of suitable material, including other metals or polymers, and be coated as noted above. The plate may be a composite of one of more materials or layers. The plate may be fabricated for example by cutting from sheet metal, pre-forming, rolling, casting or otherwise shaping. The openings in the plate may be formed using suitable methods including but not limited to drilling by mechanical or optical means such as laser drilling or ablation, or chemical processing such as etching with or without stencils or lithographic patterning. The openings may also be pre-formed at the time of forming the plate. The coatings may be pre-formed by dipping, plating, including electroplating, or otherwise encapsulating such as by molding or casting. The coatings may also be deposited by suitable deposition techniques such as sputtering, vapor deposition including physical vapor deposition (PAD), chemical vapor deposition (COD), or electrostatic powder deposition. The protective coating may have a thickness of about less than 0.1 μm to about 500 μm. It is desirable that the coating adhere to the plate102sufficiently to prevent delamination when vibrating at a high frequency.

The configuration of the reservoir1620, including the shape and dimension, can be selected based on the amount of fluid1610to be stored and the geometry of the ejector plate1602. Alternative forms of reservoirs include gravity-fed, wicking, or collapsible bladders which operate under pressure differentials. These reservoirs may be prefilled, filled using a micro-pump or by replacement of a cartridge. The micro pump may fill the reservoir by pumping fluid into or out of a collapsible container or a noncollapsible one. The cartridge may include A container which is loaded into the reservoir. Alternatively, the cartridge itself may be coupled to a disposable ejector assembly which is then replaced within the housing after a specified number of discharges.

FIG. 16Hshows a reservoir1620connected to a micro-pump assembly1670. The assembly includes micro-pump1672and a larger reservoir1671.FIG. 16Ishows a sectional view of assembly1600. An alternative reservoir for use with the device is depicted in20. Reservoir housing1608′ is coupled to the ejector mechanism. The housing1608′ includes wicking material W. This material maintains a supply of fluid against the ejector mechanism even when the fluid level falls below the ejector plate1602. Not wishing to be limited by this theory, this type of reservoir operates by capillary action. An implementation of this reservoir types is more fully described in U.S. Pat. No. 7,192,129 to Droege.

In the example shown inFIG. 16D, the reservoir housing1608has a rectangular cross-section. Other shapes can also be used. In some implementations, the reservoir housing1608includes curved edges. An example showing curved corners140is depicted inFIG. 16D. Thus, little or no fluid1610is trapped in the edges of the reservoir120and the fluid in the reservoir can be effectively used. The reservoir1620can be refillable or disposable. The reservoir can be prefilled for disposable reservoirs or can be refillable using a fill hole.

In some implementations, the reservoir housing1608includes through holes1642(only one shown inFIG. 16Ato allow air to escape from or enter the reservoir1620and keep the fluid1610in the reservoir at the appropriate ambient pressure. The through holes1642have a small diameter so that the fluid1610does not leak from the holes. Alternatively, no openings are formed in the reservoir housing108, and at least a portion, e.g., the portion1644or the entire, reservoir housing1608can be collapsible, e.g., in the form of a bladder. The entire reservoir may also be made in the form of a flexible or collapsible bladder. Accordingly, as the fluid1610is ejected through the ejector plate1602, the reservoir1620changes its shape and volume to follow the changes in the amount of fluid1610in the reservoir1620.

In the implementation ofFIGS. 16A through 17B, the ejector plate1602is activated by being vibrated by piezoelectric ejector1604. As shown inFIGS. 16A and 16C, two electrodes1606aand1606bare formed on two opposite surfaces1634and1636of the piezoelectric ejector1604that are parallel to the surface1622of the ejector plate1602and activate the piezoelectric ejector1604to vibrate the ejector plate1602. The electrodes can be attached to the plate in any known manner including fixing by adhesive or otherwise bonding. They may also be overmolded in place to plate1602. Wires or other conductive connectors can be used to affect necessary electrical contact between plate1602and the electrodes. Alternatively, the electrodes may be formed on the plate1602by plating or otherwise depositing in situ. By way of example, the electrodes are attached by adhesive1628which is applied between the electrode1606aand the ejector plate1602. Electrode1606ais in electrical contact with plate1602. When a voltage is applied across the electrodes1606aand1606b, the piezoelectric actuator1604deflects ejector plate1602to change shape to be more concave or convex as shown inFIGS. 17A and 17B. For example,FIG. 17Ashows electrode1606aand1606bcoupled to plate1602and causing the plate to deflect into shape1700. An extensive range of voltages corresponding to different piezoelectric materials are known in the art, but by way of example, a voltage differential of 40 or 60 V may be applied to the electrodes inFIG. 17A. When the direction of the voltage differential is reversed, for example to −40 or −60 the plate will deflect in the opposite direction into shape1701as shown inFIG. 17B. In this way, the actuator1604causes oscillation of plate1602which constitute the vibration that results in formation of the droplets1612from fluid1610. In the implementation shown inFIG. 17A, the volume of reservoir1620is reduced and the fluid1610in the reservoir1620is compressed by the ejector plate1602and forced into the openings1626. In the implementation shown inFIG. 17B, the volume of the reservoir1620is increased. As the alternating voltage is applied to electrodes1606aand1606b, the ejector plate1602oscillates between the shape2600and shape2602, causing the fluid droplets1612to accumulate in the openings1626and eventually be ejected from the openings1626along the direction1614away from the reservoir1620. The frequency and wavelength of oscillation may depend on many factors such as the volume of the openings1626, the number of openings1626, the viscosity of the fluid, the stiffness of the plate1602, temperature and other factors. These parameters may be adjusted or selected to create the desired droplet stream. The frequency of droplet ejection from plate1602also depends on many factors. In some implementations, the droplets1612are ejected at a frequency lower than the pulse frequency to the piezoelectric actuator1604. For example, the droplets1612are ejected every 1-1000 cycles, and more specifically 8-12 cycles, of the ejector plate vibration. A frequency of droplet ejection is discussed in more detail below.

Many piezoelectric materials can be used to create actuator1604. By way of example, in some implementations, the piezoelectric actuator can be formed from PZT. But PZT includes lead and should be sealed from fluid1610. Other lead-free materials include barium titanate or polymer-based piezoelectric materials, such as polyvinylidene fluoride. The electrodes1606aand1606bcan be formed of suitable conductors including gold, platinum, or silver. Suitable materials for use as the adhesive1628can include, but not be limited to, adhesives such as silicone adhesives, epoxies, silver paste. One example of a conductive adhesive includes Thixotropic adhesive such as Dow Corning DA6524 and DA6533. The reservoir housing1608can be formed of a polymer material, a few examples of which include Teflon®, rubber, polypropylene, polyethylene, or silicone. As mentioned earlier, all or part of the reservoir can be flexible or collapsible. The size and velocity of the droplets ejected by the ejection assembly1600can be affected by various parameters used in fabricating the ejection assembly1600. The parameters can include dimensions of the piezoelectric actuator1604, the properties (e.g., dimensions, elasticity and others) of the ejector plate1602, the size and pattern of the openings1626in the ejector plate1602, the frequency, shape, and magnitude of the pulses applied to the electrodes1606a,1606bby the drive electronics, the fluid properties (e.g., the viscosity and surface tension), and others.

The magnitude and frequency of the ejector plate vibration can also be controlled by controlling the voltage pulses applied to the electrodes1606a,1606b. As discussed above, the pulses are created by voltage differentials that deflect plate1602, as shown inFIGS. 17A and 17B. In some implementations, one of the electrodes1606aor1606bis grounded and voltage pulses, e.g., bipolar pulses are applied to the other one of the electrodes1606aor1606be.g., to vibrate the ejector plate1602. Details of the voltage pulses and other features are discussed in further detail herein. By way of example, in one implementation, the piezoelectric actuator1604can have a resonant frequency of about 60 KHz to about 120 KHz, e.g., 118 KHz. The applied voltage pulses can have a frequency lower, higher, or the same as the resonant frequency of the piezoelectric actuator1604.

In the implementation ofFIG. 16A, the delivery time of the droplets is about 0.1 ms to about several seconds. Without wishing to be bound by theory, it is believed that human eyes take about 300 ms to about 400 ms between blinks. Therefore, for implementations where delivery is desired to be between blinks, the delivery time may be about 50 ms to about 300 ms and more particularly 25 ms to 200 ms. In one implementation, the delivery time is 50 ms to 100 ms. In this way, the ejected droplets can be effectively delivered and deposited in the eye during a blinking cycle of the eye. In some implementations, for example over-the-counter saline dispensers, the delivery time can be as long as several seconds, e.g., 3-4 seconds, spanning several blink cycles. Alternatively, a single delivery can be administered by several bursts or pulses of droplet ejection.

Additionally, and not intending to be bound to this theory, pulsing might reduce the peak amplitude of the airstream by spreading the impulse out over time, similar to the effect of an automobile crumple zone during a crash. Therefore, the pressure of the ejection on the target may be mitigated. That is, e.g., for an ocular application, the subject might not feel as much air and experience higher discomfort levels. Furthermore, pulsing may also reduce droplet agglomeration and result in less entrained air generation. By way of a single example, pulses of 25 ms can be administered with stop times of 25 ms separating the pulses. By way of example, in one implementation, the pulses may be repeated for a total of 150 ms total time.

FIGS. 21A-Dshow another implementation of the housing of the device. The housing502formed by components molded from plastic or other suitable material is generally defined by a front portion2104and a rear portion2106. The front portion2106includes a fluid delivery area2108and an activation mechanism2110. The fluid delivery area2108further defines a delivery aperture2112formed through a cover bezel2114and through the housing. The fluid delivery area2108also includes a multifunction LED2116having a function as described earlier with respect to other implementations. The activation trigger2110includes an aperture cover plate2118and a thumb rest2120. One or more raised edges2122may be formed around the perimeter of the thumb rest520to assist with positioning the thumb of a user on the activation trigger2110. In the implementation shown, the cover plate2118and thumb rest2120may be formed integrally in one piece or in multiple parts. The cover plate2118fits within a slot formed by the front portion2104and the cover bezel2114(FIG. 5E) and is operable to slide up and down within the slot thereby allowing the cover plate2118to seal the delivery aperture2112and protect the ejector assembly behind the aperture and internal components from external debris and contamination. Optionally, a back surface of the cover plate2118may be coated with material containing silver particles to prevent bacteria from forming in and around the inside of the delivery area.FIG. 21Fis a schematic diagram depicting a user aligning the device in the direction of their eye prior to delivering a dose of ophthalmic fluid droplets. The ergonomic design of the device allows the user to place their thumb on the thumb rest located on the device and promotes the thumb to take on a slightly bent position. The proximal phalanx of the thumb may then be placed against the user's cheek bone for steadying the device while the user aligns the delivery aperture with their eye. A multifunction LED, including optionally, a back-lit polished ejector plate, may also aid in alignment. When the user's thumb is placed against their cheek bone, the delivery aperture can be easily aligned at the optimal distance of 2-3 cm from the eye's surface. The user may then locate their index finger on the delivery button, and when ready may depress the delivery button for delivering ophthalmic fluid to the surface of their eye.

Thus, the combination of the position of the thumb rest and the placement of the back of the thumb on the cheek bone provide a natural and repeatable alignment feature and process. Depending on the user's anatomy, a different portion of the thumb or hand may be aligned with an alternate location on the face to affect proper alignment. Alternatively, the device can be held a suitable distance during use, for example, as noted with respect to distance d shown inFIG. 16A. The suitable distance may vary with the type of subject and application. For example, for veterinary subjects, the device may be held a longer distance than for a human subject. Additionally, the device may be held in the palm of the hand and aligned without using the hand or its digits and instead with a spacer or aided by an alignment device as described above. Alternatively, any portion of the hand or its digits can be used to the device and any portion of the hand or its digits may be used to activate the delivery button. By way of example, the device can be held in the hand with the pinky spacing the device from the face and the thumb depressing a delivery button located on the side of the device housing.

During use, the device is held, turned on, aligned, and the delivery button depressed. Turning on the device may manually occur by activation of a physical activation trigger or may occur automatically or in response to a condition, e.g. removal of the device from a docking station. The device may cycle through a cleaning cycle once activated. The properly aligned housing delivers the fluid in the form of the droplet stream to the target.

FIG. 22Ashows a communication system that includes the fluid ejection device. The device may be used in combination with a docking station. Details of this system and a docking station are more fully disclosed in the U.S. application Ser. No. 13/184,468, entitled “Method and System for Performing Remote Treatment and Monitoring,” filed concurrently herewith and incorporated herein by reference.

FIG. 22Bshows a block diagram showing a device2202and a docking station2250in communication. The device2202may include a housing2206, electronics2208, an ejection mechanism actuator, e.g., piezo2210, a reservoir2212, a targeting device2214, an electronic storage2216, and an input/output (I/O) interface2218. The device2202also may include an imaging device2220, a lookup table2222, a speaker2224, and an LED2226.

The housing2206may be made from, for example, injection molded plastic or any other suitable, durable, or lightweight material. The housing2206may include an opening2228, a positionable slider2230, an interface2232that sends communications to and receives communicates from the docking station2250, a stream activator2234, and a communications interface2236. The communications interface2236sends data to and receives data from a source external to the housing2206(see U.S .application Ser. No. 13/184,468, entitled “Method and System for Performing Remote Treatment and Monitoring,” filed concurrently herewith, and herein incorporated by reference in its entirety) to the device2202, and the docking station2250. For example, the communications interface2236may be in communication with the database or with an input/output device, such as a keyboard.

The opening2228may be in the form of an aperture formed through an exterior surface of the housing2206, and the opening2228allows fluid stored in the reservoir2212to exit the housing2206. The opening2228may be similar to those explained earlier.

The positionable slider2230, which may be similar to the thumb slider described earlier. The housing2206also includes an interface2232configured to receive the connection2204. The connection2204may be, for example, a one-wire, two-wire, or12C interface. The interface2232allows the device2202to send data to and receive data from the docking station2250over the connection2204.

The housing2206also includes an activation trigger2234. The trigger may be, for example, a button that protrudes from the exterior surface of the housing706, a switch, or any other tactile interface that is accessible to a user of the device, such as the switches described above. The trigger2234may be on a side of the housing2206that is opposite from the side of the housing2206that includes the opening2228and the slider2230.

The housing2206also may include a communications interface2236that is in communication with the electronic storage2216and allows retrieval of data stored in the electronic storage2216and writing of data to the electronic storage2216. The interface2236may be, for example, a universal serial bus (USB) connection, a serial connection, an Ethernet connection, or any other connection that allows reading and writing of data. Further discussion of these aspects appears in U.S. application Ser. No. 13/184,468, entitled “Method and System for Performing Remote Treatment and Monitoring,” filed concurrently herewith.

The device2202includes the electronics2208, which provide one or more output driver signals to the ejector mechanism actuator or piezo2210. The piezo2210vibrates, moves, or distorts the ejector plate2202in response to application of the output signals. The ejector plate2202is in contact with fluid stored in the reservoir2212, and, when the piezo2210distorts, fluid from the reservoir2212is pulled through one or more openings formed in the ejector plate. In the piezoelectric implementation, the motion of the ejection plate, and in general, the operation of the ejection mechanism, causes a directed stream of droplets to exit the housing2206through the opening2228.

As discussed in greater detail with regard to figures disclosing electronics, the electronics2208determine the frequency, voltage, duty cycle, and duration of the output driver signal2342that is applied to the piezo2210. Additionally, the electronics2208are programmable such that the characteristics or properties of the output driver signals applied to the piezo2210may be adjusted to accommodate changes in the fluid and/or a dosage plan.

FIG. 22Cincludes a processor2304and a driver circuit2306. The processor2304provides a excitation signal2340to the driver circuit2306, and the driver circuit2306generates an output driver signal2342that is applied to the piezo2210. The properties of the output driver signal2342are determined from the properties of the excitation signal2340. As discussed below, the output driver signal8232may include, for example, two or four separate output driver signals.

The reservoir2212may be pre-filled with fluid when the device2202is manufactured. The device2202may be programmed at the time of manufacture of the device2202. Alternative reservoirs as discussed can be used without limitation.

The device2202also includes the targeting device2214. The targeting device2214may assist the user to align the device2202with an eye of the subject. The targeting device2214may be, for example, an LED that shines in the subject's eye, a reflective or shiny surface that reflects the subject's eye, and/or a CCD camera that images the subject's eye and provides a signal to the electroVINNOnics2208. The targeting device2204may include a reflector to provide the user with an image of his or her eye when the device2202is correctly positioned, or may include a light source, such as a low intensity LED, for shining into the user's eye when the device2202is correctly positioned. The targeting device2214may include a sensor that determines whether or not the subject's eye is open. The targeting device2214may include an element that shows a reflection of the subject's eye when the device2202is properly aligned with the eye. For example, the ejector plate and/or piezo2210may be made from a reflective material that shows a reflection of the subject's eye when the opening2228and the piezo2210are aligned with the subject's eye. This type of targeting device is helpful for instances where the subject is using the device2202to administer a directed stream of droplets to their own eye.

In alternative implementations, all or part of the surface of the ejector mechanism or the housing adjacent thereof may be coated with a reflective layer. A coating layer may be both protective and reflective. Alternatively, the surface may have been formed to be reflective. For example, the surface may be made of stainless, nickel-cobalt, or other reflective material. A surface may have been formed or polished to be reflective. In addition to making the surface reflective, the surface may also be backlit on its surface or around its perimeter. In ophthalmic applications, a reflective surface aids the user in aligning the ejector assembly with the eye.

The device2202also includes the electronic storage2216and the I/O interface2218. In addition to storing data such as images of the subject's eye, the electronic storage2216stores instructions, perhaps as a computer program, that, when executed, cause a processor included in the electronics2208to communicate with other components in the device2202. The processor may be, for example, a state machine such as an FPGA or an ASIC. The excitation signal2340may be generated by a signal generator. Information on the electronic storage2216may be accessed through the interface2218or the interface2236(which communicates with a database), and access to the contents of the electronic storage is controlled, e.g., password restricted to allow certain activities to be conducted by certain medical personnel, e.g., doctors or pharmacists wishing to adjust dosages. Insofar as the computer is Internet enabled, information may be uploaded to via the Internet, e.g. to a server for access by medical personnel to allow progress and proper subject use to be monitored and allow dosages to be adjusted over the Internet, e.g., by uploading revised dosage information to a server by the medical personnel and then pushed to the device via the Internet or downloaded by the user. The device itself may be Internet enabled to allow usage information and image information to be uploaded in real time and new information to be downloaded to the device in real time. Insofar as the device is Internet enabled it may be provided with a user interface, e.g. screen and keyboard or touch sensitive screen.

The input/output interface2218provides an interface that allows data and/or commands to be input to the device2202and/or read from the device2202. The input/output interface2218may receive data from a device such as a keyboard, a mouse, a communications port, an electronic processor executing on a device separate from the device2202, or a display. The input/output interface2218also may include software that allows communication between the device2202, the components of the device2202, and/or an external device. The interface2218may provide the user with access to the device2202when the device2202is plugged into a computer, such as a laptop or palmtop or cellular phone with screen and user input capabilities, through the interface2218.

The device2202also may include an imaging device2220. The imaging device2220may be a charged coupled device (CCD) that is aligned with the opening2228such that the imaging device captures an image of the subject's eye through the same aperture that delivers the directed stream of droplets of fluid. In some implementations, the imaging device2220is mounted on an external surface of the housing706in a location other than the location of the opening2228. Images collected by the imaging device2220may be transferred from the device2202through the I/O interface2218, the communications interface2236or2256, and/or the images may be stored in the electronic storage2216. The images may be uploaded to the database and stored in association with the subject's medical records, as more fully explained in U.S. application Ser. No. 13/184,468, entitled “Method and System for Performing Remote Treatment and Monitoring,” filed concurrently herewith and herein incorporated by reference in its entirety.

The imaging device2220and the electronics2208may be operable to control the capture of images during or at selectable times before or after ejection of fluid from the device2202. In some implementations, the capture of images may be triggered by the user by, for example, depressing a button or the stream activator2234. For example, saline droplets may be directed from the device2202towards the eye to exert a pressure on the cornea and images may be taken to determine the effect. The images may be saved as discussed above.

The device2202also may include the look-up table2222. The look-up table2222may be stored on the device2202, for example, in the electronic storage2216, or the look-up table may be stored separately from the device2202, for example, in the database. The look-up table2222includes information specific to fluids that may be used in the device2202. For example, because viscosities of fluid drugs vary, depending on the fluid in the reservoir, the piezo2210may require application of output driver signals having a frequency tailored to the fluid in the reservoir. This medication-specific variation may be accounted for by varying the properties, such as the frequency, voltage, and/or duration of the output driver signals produced by the electronics2208and applied to the piezo2210. The look-up table2222may include information specific to the medication that is retrieved and used by the electronics2208to set the output driver signals.

The look-up table2222also may include medication-specific information that relates to the subject's treatment plan. For example, the look-up table may include information specifying that a first medication is to be applied three times a day, while a second medication is to be applied once a day. This treatment plan information is used by the electronics2208to determine, for example, when to trigger a reminder alert for the subject based on the type of medication that is placed in the reservoir.

In some implementations, the look-up table2222on a specific device2202may be edited by a professional, e.g., medical professional to account for changes in the subject's condition. The interface2236may be operable to download information, for example, via an external I/O device or directly from the database, perhaps via the Internet. The downloaded information may include one or more of revised dose amounts, revised dose times, and medication type to be dispensed. The device2202may be configured such that the electronics2208controls the dispensing of medication in response to pre-defined information or the downloaded information.

The device2202also may include a speaker2224and an illuminator2226, both of which may be used, in conjunction with the electronics2208, to provide a perceivable alert to the user of the device2202. The device702may provide other perceivable alerts. For example, the device2202may vibrate to attract the user's attention. The device2202may produce an audible alarm or enunciator, or visual indicator controllable by the electronics2208to provide feedback to the user, for example, visual or audible feedback to indicate when a full dose has been reached. The illuminator2226may be an LED or other device that emits visible radiation in response to electrical input.

In some implementations, the illuminator2226may include multiple light sources of different frequencies for illuminating the eye, or may include a variable frequency light source, such as light of different colors and frequencies (e.g., red, blue, green, white, infrared (IR), ultraviolet (UV)). The device may include a cobalt blue light (generated, for example, by using a filter) for use with fluorescein to illuminate the cornea for identifying corneal ulcers and scratches. The illuminator726may be a radiation source that emits frequencies above 280 nm wavelengths for illuminating the eye. The illuminator2226may be operable to pulse the light for different periods of time, for example, 20 nanoseconds (ns) to limit pupil reaction and permit analysis of the eye with different frequency optical detectors, scanners or cameras. The illuminator2226may include an adaptive optics chip to perform wavefront correction for clearer images, for example, a MEMS based adaptive optics chip.

The device may also include a fixation source e.g., an LED or LED pattern to define a moving eye-focusing image and assist with pediatric usage. This also serves to move or rotate the eyeball during application of medication to assist in spreading the medication across the corneal surface.

The docking station2250includes a housing port2252(including without limitation, a docking station) that is configured to receive the device2202. The housing port2252may be recessed such that, when the device2202is received by the docking station2250, the device2202is seated securely and is stably held by the docking station2250. The docking station2250also may include a communications interface2256that reads and writes data from the docking station2250and/or the device2202. The communications interface2256may be, for example, a USB connection, an Ethernet connection, or a serial connection. The docking station2250also may include a memory or an electronic storage2254.

The electronic storage components2216and2254may be volatile memory, such as RAM. In some implementations, and the electronic storage components2216and2254may include both non-volatile and volatile portions or components.

FIG. 23Ashows a top view of an example configuration2300for the electronics used in the device, andFIG. 23Bshows a bottom view of the configuration800. Although the following description is discussed with respect to the device2202, the configuration2300, or a similar configuration may be employed in the device. The configuration may be implemented on a printed circuit board (PCB) sized to fit into a housing that is small enough to be held in a single human hand. The configuration may be implemented on a single PCB board, or on multiple PCB boards. In the example shown inFIGS. 8A and 8B, the configuration is implemented on a single PCB board2301.

Referring toFIG. 23A, a top view of the configuration2300is shown. The top view includes a reservoir2302, and a processor2304, the driver circuit2306, a push switch2308, a programming interface2310, and a slide switch2312. The processor2304may be a logic circuit with a free running oscillator designed to control and sequence the signals used to control pulses to the ejector and the formation of the droplets. Alternatively, a field programmable gate array (FPGA), an application specific integrated circuit (ASIC), a complex programmable logic device (CPLD), or a Erasable Programmable Logic Device (EPLD) may be used as the processor. Alternatively, a microprocessor or other programmable processor such as a PIC18F14K50-I/SS microcontroller, available from Microchip Technology, Inc. of Chandler, Ariz., FPGAs and ASICs are generally less costly than microprocessors. Logic circuits and free running oscillators, such as the LM555 used in both the astable and monostable modes, are also less costly and afford high accuracy in signal control. In some implementations, any low-power processor having a voltage range of approximately 2.4 to 6 volts that generates a clock signal and has a sleep or low-power mode may be used as the processor2304. The driver circuit806may be, for example, a LT3572EUF#PBF motor driver, available from Linear Technologies of Milpitas, Calif. Additionally, the device may include a microcontroller with a watchdog timer which monitors the device to ensure proper operation.

The driver circuit2306is controlled by, and receives the excitation signal2340at a particular frequency from, the processor2304. Controlling the driver circuit2306with the processor may provide a system that has increased flexibility and applicability as compared to a system that relies on a driver circuit alone. For example, controlling the driver circuit with the processor allows the frequency of the output driver signals2342produced by the driver circuit to be determined and changed quickly by modifying the properties of the drive signal2340produced by the processor. This may allow the device2202to adapt to changing subject needs and to operate with the various fluids that may be placed in the reservoir2302. Additionally, controlling the driver circuit2306with the processor2304may eliminate the need for a separate potentiometer to control the frequency of the excitation signal2340. Use of the processor2304to control the driver circuit2306may allow the electronics2208to be reduced in size such that the device2202may be held and operated by a single human hand.

The processor2304receives data and control signals from a push switch2308, a programming interface2310, and a slide switch2312. The processor may be connected to the driver circuit through an electrically conductive path2314, such as a copper trace. The push switch2308, the programming interface2310, and the slide switch2312may be electrically connected to the processor through traces2314,2316, and2318, respectively.

The push switch2308is coupled to the activation trigger2234, the mechanism by which a user of the device2202causes release of the directed stream of droplets. The push switch2308and a portion of the stream activator2234may physically contact each other when the user of the device2202presses or otherwise selects the stream activator2234. In implementations in which the stream activator2234is electronic (for example a softkey), the stream activator2234may not necessarily be in physical contact with the push switch2308, rather the stream activator2234may provide an electronic indication of selection to the push switch2308. In response to receiving an indication of activation from the activator trigger2234, the push switch2308generates a spray signal to the processor2304.

The programming interface2310allows the processor2304to be programmed to, for example, produce a excitation signal2340that has a particular frequency, duration, or time between active states. For example, the processor2304may be programmed to generate a excitation signal2340having a frequency between about 108 kiloHertz (kHz) and 183 kHz. The programming interface2310may be, for example, a 5-pin interface. In some implementations, the programming interface2310may be accessible through a graphical user interface (not shown).

The processor2304provides the excitation signal2340to the driver circuit2306, and the driver circuit uses the excitation signal2340to produce two output driver signals that are applied to the piezo2320. Each output driver signal2342may be a square wave, or approximately a square wave, and each output driver signal2342may have approximately the same maximum and minimum voltage. The maximum voltage of the output driver signals may be approximately 20 to 40 volts, and the minimum voltage may be approximately zero (0) volts. The second output driver signal2342may be out-of-phase with the first output driver signal, and the first and second output driver signals may be out of phase by approximately 180 degrees.

The slide switch2312is coupled to the slider2330. For example, in implementations in which the slider2230is a physical slider, the slide switch2312may be physically connected to the slider2230such that the slide switch2312generates a signal when the slider2230is positioned in one or more pre-defined positions on the housing2206. In some implementations, the slider2230may be electronic and may communicate with the slider switch2312electronically instead of mechanically. The slider2330also may be provided with a metalized surface operable, when the slider2330is moved into the open position, to bridge the gap between two metal contacts, thereby defining a slide switch. The slide switch2312may generate a signal when the slider2230is moved to a position that reveals (or uncovers) the opening2228. This signal may be referred to as an initiation signal. The slide switch2312may generate another signal when the slider2230is moved from that position. Signals generated by the slide switch812are provided to the processor2304.

Referring toFIG. 23B, a bottom view of the configuration2300is shown. The bottom view is shown as the mirror image of the top view ofFIG. 23A. The bottom view shows a piezo2320, an LED2322, the driver circuit2306, the processor2304, a speaker2324, a power module826, and a remote control module2328.

The piezo2320holds and/or is in contact with the ejector plate1602(FIG. 16A) that contacts a fluid held in the reservoir2302, and the piezo2320receives the output driver signals from the driver circuit2306through a conductive path2330. The piezo2320moves, vibrates, distorts and/or changes shape in response to application of the output driver signals842from the driver circuit2306.

In one implementation, the piezo2320is mounted on the printed circuit board (PCB)2301and contacts a conductive surface (not shown) on the PCB board2301. The conductive surface may be stainless steel. In some implementations, the conductive path830is a discrete wiring, not integrated with the board2301, that connects the piezo2320to an output of the driver circuit2306. In some implementations, the conductive path2330is a trace made directly on the PCB board2301. In these implementations, a conductive material is placed between the piezo820and the o-ring and reservoir2302. The conductive material may be, for example an elastomer or “Zebra strip.” In these implementations, the discrete wire is eliminated and the output driver signal2342from the driver circuit2306is provided to the piezo2320by a conductive trace formed directly on the PCB board2301. The piezo2320may be aligned with the opening2228to allow the directed stream of droplets to exit the device2202.

In some implementations, the configuration800includes a second piezo that is coupled to the reservoir that is mounted on the top of the PCB board. In this implementation, the driver circuit2306is configured to generate four output driver signals2342to drive the two separate piezos. The second piezo may be mounted directly to the surface of the reservoir2302such that the reservoir2302vibrates with the second piezo. This vibration may help to ensure that the fluid in the reservoir2302remains in a fluid state and to help prevent the formation of crystals and other solid particles in the reservoir2302. In the case of medications provided as a suspension, the vibration may be operable to churn up the medication.

The LED2322receives power from the power module2326and a signal to turn ON or OFF from the processor2304. The processor2304also provides a signal to the speaker2324to turn ON or OFF. The configuration2300includes a remote control module2328that allows for remote configuration and/or control of the processor2304. The power module2326may be one or more batteries. For example, the power module2326may include three batteries.

FIG. 24shows an example process2400for operating a device that delivers a directed stream of droplets to a subject's eye. The process2400may be performed using, for example, the device. The process2400may be performed by the electronics2208or the processor2304. The process2400may be performed by the processor2304in conjunction with the driver circuit2306. An indication of activation of a tactile device is received2402. The tactile device may be, for example, the stream activator2234, and the indication of activation may be the spray signal that is generated by the push switch2308when the stream activator contacts the push switch2308physically or interacts with the push switch2308electronically. The indication of activation results from a user of the device2202specifying that a directed stream of droplets of fluid is to be released from the device2202.

Whether an opening in the housing is substantially free from obstruction is determined2404. The directed stream of droplets is released from the device2202when the slider2230is in a position that reveals, rather than covers, the opening2228. When the slider2230is positioned in a position on the housing that reveals the opening2228, the slide switch2312generates a signal that is provided to the processor2304. If this signal has not been generated, the opening2228is not substantially free from obstruction. If the signal has been generated, the opening2228is substantially free from obstruction such that a directed stream of droplets may be released from the device2202.

An excitation signal is generated in response to receiving the indication of activation and determining that the opening in the housing is substantially free from obstruction2406. The excitation signal2340is applied to the driver circuit2306, which in turn generates two voltage signals (output driver signals) that are applied to the piezo2320(or piezo2210) to cause the piezo and the ejector plate1602attached to the piezo to vibrate, move, or otherwise distort. The motion of the ejector plate1602draws fluid from the reservoir2302and through one or more holes in the ejector plate, creates a directed stream of droplets of fluid for delivery to the subject's eye. The excitation signal2340may be a square wave having a frequency of about 95 kHz to 183 kHz. The excitation signal2340is applied to the driver circuit2306, and the driver circuit2306produces two square wave output driver signals that are 180° out of phase with each other and that are applied to the piezo2320. The voltages of the square wave output driver signal2342may be, for example, 20 to 40 volts, and the frequency of each output driver signal2342may be between about 95 kHz to 183 kHz.

FIG. 25shows another example process2500for operating a device that directs a stream of droplets of fluid to a subject's eye. The process2500may be performed using, for example, the device. The process2500may be performed by the electronics2208or the processor2304. The process2500may be performed by the processor2304in conjunction with the driver circuit2306.

An indication that a thumb slide has moved into a second position is received (2502). The thumb slide may be a slider similar to the slider2230, and the second position may be a location on the surface of the housing2206that reveals the opening2228such that the directed stream of droplets may exit the device2202. The indication of that the slider2230has moved may be a signal generated by the slide switch2312in response to the slider making mechanical or electrical contact with the slide switch2312. A excitation signal2340is generated in response to receiving the indication (2504). The excitation signal2340may be generated by the processor2304, and the excitation signal2340may be a signal that controls the driver circuit2306to produce output driver signals that drive the piezo to perform a preparation sequence. The preparation sequence may be referred to as an initiation sequence, a purge cycle, or a cleaning cycle.

The preparation sequence causes the device2202to produce one or more directed streams of droplets that are not intended for placement in the subject's eye. Rather, the one or more streams produced in the preparation sequence flush out the barrier, the hole in the barrier, the reservoir, and other internal components of the device2202. The preparation cycle may reduce or eliminate contaminants and residues that may accumulate in the device2202between uses. In some implementations, about 8 to 10 directed streams of droplets are produced during the preparation sequence. Although the directed stream of droplets released during the preparation sequence is not intended for placement in the subject's eye, the medication in the reservoir is used as the fluid during the preparation cycle to clean and/or prepare the device for use.

In some implementations, the drive signal2340applied to the driver circuit2306causes the driver circuit to produce two output driver signals with a waveform having a cycle that lasts for a total of about 50 milliseconds, and for about 30 milliseconds of the cycle while the output driver signal2342is ON, and for about 20 milliseconds while the output driver signal2342is OFF (that is, essentially no output driver signal2342is applied to the piezo). The preparation cycle may include applying these output waveforms to the piezo for about 8 to 10 cycles of the waveform. When the output waveform is ON, the piezo vibrates and draws fluid from the reservoir through the barrier to clean the components of the device2202.

An indication that the preparation sequence is complete is received2506, and a perceivable alert is presented upon completion of the preparation sequence2508. The perceivable alert may be, for example, the LED2322turning ON. The alert lets the user of the device2202know that the device2202is ready for use. If an indication of an activation of a tactile interface is not received within a predetermined amount of time after the completion of the preparation sequence, a sleep mode is initiated2512. If an indication of an activation is received within the predetermined amount of time, it is determined whether the opening in the housing is substantially free from obstruction such that a directed stream of droplets may exit the housing2206.

If an indication that the thumb slide has moved into a first position is received, then the sleep mode is initiated2512. The first position may be a position in which the thumb slide covers the opening in the housing. If an indication that the thumb slide has moved into the first position has not been received, the device2202remains ready to receive an input from the user until a predetermined amount of time has elapsed. After the predetermined amount of time has elapsed, the sleep mode is initiated.

The processor2304may be programmed to dispense only a predetermined number of dosages, such as 30 dosages, 60 dosages, or180dosages, and additional activation of the tactile interface does not produce a directed stream of droplets.

Other alternative implementations are also contemplated. By way of example, in one implementation, ejection plates are created by precise micro fabrication techniques. A size of microspheres ejected from such a plate will vary in volume according to the magnitude of plate motion. The frequency of the plate motion is influenced by the frequency of an electrical voltage (typically a square wave) that drives the piezoelectric actuator attached to the ejector plate. Typically the actuating frequency will be in the range of 50 kHz to 200 kHz and will have a duration great than about 0.1 milliseconds.

Drug volume per dose is calculated from the diameter of the ejected spheres, number of holes in the plate, frequency of vibration, number of voltage cycles per ejection per hole, and length of time the plate is vibrated. For example an ejection plate having 1000 holes that are 20 microns in diameter may eject spheres about 40 microns in diameter. If a sphere ejects from each hole about once per ten cycles then a 100 kHz vibration from the piezoelectric element will eject about 100,000/10 spheres per hole per second or about 10,000,000 spheres per second when all 1000 holes are ejecting fluid. If each sphere is 40 microns in diameter then the ejector plate will dispense about 10,000,000*4/3*pi*((40e-6)/2)^3 cubic meters per second or about 10,000,000*4/3*pi*((40e-3)/2)^3=335 microliters per second. If the plate is actuated for 20 milliseconds then about 6.5 microliters of drug are ejected.

Without being limited by theory, sphere size and velocity are related to the amplitude and frequency of the waveform voltage driving the piezoelectric element. In part, this is because magnitude of the ejector plate motion and piezoelectric motion is related to frequency of the driving signal. Magnitude of the piezoelectric motion is related to the voltage of the applied voltage. Ejection velocity is also dependent on the frequency and magnitude of the applied voltage. In some implementations, spheres are not effectively ejected except near resonant frequencies or their harmonics. In an implementation, spheres ejected at these frequencies will be optimized for maximum speed and volume. Unfortunately, variation in manufacture of piezoelectric elements can cause resonant frequencies to vary about 10% from the average. This variation results in each dispense unit needing a slightly different voltage or frequency to achieve the same dispense velocity and volume. Each unit can be tuned during manufacture for a specific frequency. The oscillation of the piezoelectric element is highly dependent on frequency. Therefore, optimization of frequency is a often needed and control of the frequency of a square wave can be accomplished by changing the frequency of the internal square wave generator (typically a microprocessor or FPGA).

In certain implementations of a portable device, voltage and power applied to the piezoelectric element can be limited by breakdown voltages of electrical components and total battery energy. Voltage can be minimized to reduce power consumption while still achieving optimal ejection of spheres. Tuning the frequency slightly off the resonant frequency allows control of the ejection velocity and plume shape for a given applied voltage. Similarly total mass ejected per dose is controlled by the duration of ejection. Thus a final tuning of driving frequency and pulse time is needed to set ejection velocity and dose volume.

One implementation described here is a device and method for tuning the ejection velocity and dose size for a portable ophthalmic dispenser. In an implementation of this a small target plate with an associated weighing mechanism and a vision system that observes the region between the dispenser and target plate. A test fixture controller dispenses the dose for a fixed time and receives the weight and velocity of the dispensed dose. A controller calculates appropriate modifications in the ophthalmic delivery device. A ophthalmic dispenser has a programmable internal controller with static memory (such as EEPROM) to store optimized parameters.

A vision system will measure the velocity of the dispense. Typical dispense velocities are in the range of 0.5 to 10 meters per second with typical time of flight of 4 to 80 milliseconds travelling a distance of 4 cm. Thus a camera with a frame rate faster than 100 frames per second and ideally 10,000 frames per second would measure the leading edge of a dispense as it travels from the dispenser to the weighing station. Accuracy of measuring the front edge of the droplets depends upon an effective illumination source, effective optics, and the camera's resolution.

In one implementation operation, a dispenser will be placed in the tuning station in a rigid jig (or brought to the test area in a jig) with electrical connections to the dispenser. A dose will be dispensed towards the target about 4 cm away as the vision system measures the velocity of the front edge of the ejected droplets. Then the target will be weighed. A controller then calculates the dispense volume and velocity. Typically dispenses will be done at multiple frequencies to determine the optimal dispense frequency for correct droplet velocity. Dosage per dispense will be measured by the weighing system at this frequency and then dispense time will be set to a value that gives the correct dosage.

At appropriate times the dispense fluid is cleaned from the target with a blast of air followed by another weighing to tare the system. For accurate dose measurement multiple dispenses may be done to increase the total mass measured. Then, an average can be taken to determine the mass of a single dose.

Additionally, a vision system can be used to verify the width of the dispense plume and even infer droplet size according to the degree to which the droplets are carried around the target by the airflow. This data can be collected in one or two directions (for example, from above or from the side) to verify aim of the dispenser plate if needed. Similarly, a vision system that observes droplet flight from the side can infer dispense velocity and droplet size from the amount that the dispense falls below the target. With higher dispense velocities the vertical position of the droplets will change less.

In order for this system to work, each portable device may have an externally programmable memory to hold the calibration constants or formula for piezoelectric frequency and pulse duration. For consumer and particularly prescription applications, each unit can, if desired for that implementation, store the number of doses it is allowed to dispense. Knowing the volume of the fluid is allows for overfilling, which can optionally use for calibration sprays and cleaning sprays which may occur each time the unit is opened. In one implementation a entire ejector plate wetted for a full-dose dispense. A full wetting requirement may result in excess drug that can be stored in the dispenser so that at the end of user dosing there will be drug left in the dispenser.

In one implementation, number of doses ejected can be restricted both for the consumer to prevent partial doses being used and for the supplier of the device so that per dose is accurately accomplished. For example, if a unit was 20% overfilled then the consumer might buy 20% fewer units on an annual basis in the case of long-term use of the device.

In one implementation, along with calibration constants and dose limits, the memory may be programmable to allow the same unit to dispense different sized doses in the case where a smaller person or child should receive smaller doses of the drug. Similarly, in cases where the unit should alert the user if a dose is overdue, as in the case of a glaucoma medication where regular application of the drug is key to minimizing damage by the disease, medication intervals and even an internal clock might be set. For example, during the day doses might be required every four hours but no doses are required from 9 pm to 6 am when the person is sleeping. In one implementation, a point of calibration of the dispense system or later during packaging or prescription sales the user constants might be downloaded to the device.

Many implementations of the invention have been disclosed. This disclosure contemplates combining any of the features of one implementation with the features of one or more of the other implementations. For example, any of the ejector mechanisms, or reservoirs can be used in combination with any of the disclosed housings or housing features, e.g., covers, supports, rests, lights, seals and gaskets, fill mechanisms, or alignment mechanisms. Further variations on any of the elements of any of the inventions within the scope of ordinary skill is contemplated by this disclosure. Such variations include selection of materials, coatings, or methods of manufacturing. Any of the electrical and electronic technology can be used with any of the implementations without limitation. Furthermore, any networking, remote access, subject monitoring, e-health, data storage, data mining, or internet functionality is applicable to any and all of the implementations and can be practiced therewith. Further still, additional diagnostic functions, such as performance of tests or measurements of physiological parameter may be incorporated into the functionality of any of the implementations. Performance of a glaucoma or other ocular tests can be performed by the devices as a part of their diagnostic functionality. Other methods of fabrication known in the art and not explicitly listed here can be used to fabricate, test, repair, or maintain the device. Furthermore, the device may include more sophisticated imaging or alignment mechanisms. For example, the device or base may be equipped with or coupled to an iris or retina scanner to create a unique id to match a device to the user, and to delineate between eyes. Alternatively, the device or base may be coupled to or include sophisticated imaging devices for any suitable type of photography or radiology.

To assist in understanding the present invention, the following Example is included. The experiments described herein should not, of course, be construed as specifically limiting the invention and such variations of the invention, now known or later developed, which would be within the purview of one skilled in the art are considered to fall within the scope of the invention as described herein and hereinafter claimed.

EXAMPLE

An implementation of the disclosure may be carried out through this Example. Although many arrangements are possible, one implementation uses an annular PZT piezo attached directly to a circular 80 microns thick Ni—Co ejector plate, having a diameter of 0.5 cm. The ejector plate contains eighty-nine 30 microns cylindrical holes bored through the center with a 380 microns center-to-center distance between adjacent holes. A 60 Vpp amplitude square wave is applied to the piezo at the resonant frequency (108.0 kHz) causing the ejector plate to oscillate at approximately the same frequency.

When operating with these parameters, the device produces droplets with a size distribution in which the median diameter is 55 microns. In this example, it is assumed that the ideal range for the device is 3.0 cm orthogonally from the plane of the target. If the target has a bottom-to-top target diameter of 8.0 mm, then the average distance that a droplet could fall due to gravity before leaving the target is 4.0 mm. The terminal velocity for a 55 microns water droplet is 0.09 m/s. Therefore it takes at least 0.044 s to fall 4 mm. Assuming that the average horizontal velocity of a droplet is ½ the initial velocity, the minimum initial velocity needed to propel the droplet to a target 3.0 cm away in 0.44 s is 1.4 m/s.

Droplets with a diameter of 55 microns have an evaporation time of approximately 3 seconds. Therefore, a particle traveling at the minimum velocity needed to reach the eye would still contain greater than 99% of its initial volume upon impact with the eye. See, e.g.,FIGS. 27 and 28.

Without accounting for entrained air effects, the momentum to drag force ratio (relaxation time) of this median sized particle would be 0.0093 s, leading to a theoretical stopping distance of 9.3 mm. However entrained air reduces the drag force on droplets, increasing the effective range by up to one order of magnitude.

Measurement and analysis of particle diameter was performed with a Malvern Spraytec instrument. This system uses a 632.8 nm laser collimated to a 10 mm diameter beam. When the laser interacts with particles in its path, light is scattered at various angles depending on the droplet size. A lens focuses the scattered light onto photodiode detector elements. The control software subtracts electrical and optical background noise, applies a multiple scattering correction filter, and then calculates the droplet size distribution as a function of time.

Mass deposition experiments were performed with a 20 MHz BK Precision 4040A function generator, a NF Electronic Instruments4025high speed power amplifier/bipolar power supply, and an Ohaus Pioneer PA214 digital scale (210 g capacity×0.1 mg resolution). Glass slides (7.5 cm×7.5 cm) were used to collect droplets ejected from the Corinthian Ophthalmic drug delivery invention. These large slides are important to observe the effect of entrained air on mass deposition. An Edmund Optics 36 inch dovetail optical rail was used to vary the mass deposition distance while maintaining straight line accuracy.

Droplet size distributions were measured with the Malvern Spraytec instrument and software. A droplet generating device was maintained at a constant distance of 3.0 cm from the center of the collimated laser beam and sprayed horizontally into the beam. The function generator was used to drive the high speed power amplifier using pulse-width modulation. The high speed power amplifier produced a square wave with 108.0 kHz frequency, pulse width of 0.150 s, 50% duty cycle, and 60 Vpp amplitude, thereby driving the piezo at its resonant frequency. The Malvern Spraytec triggered to begin measurements when laser transmission dropped below 98%.

Dose effectiveness measurements were performed by observing the mass deposition on the glass slide at distances of 0.0-6.0 cm from the ejector plate. This experiment was performed on 5 different ejector plate hole sizes.

The graphs are normalized to 100% mass deposition, and plotted as a function of distance and median particle diameter as measured by the Malvern Spraytec device (FIGS. 29Aand B).FIG. 29Ashows how the 10 and 17 microns particles only delivery a partial dose (68-85%) at distances of 3 cm. However, the 32, 56, and 70 microns particles deliver 92-99% of the dose at 3 cm. At a larger distance of 6 cm, the 10 and 17 microns particles appear to only deliver 21-51%, while the 32, 56, and 70 microns particles appear to deliver 70-84% of the original dose. This figure suggests that droplet size is a relevant variable to consider when attempting to deliver ophthalmic fluids with an ejector-type delivery device.

Droplets with insufficient mass will have a low momentum to drag force ratio as shown in equation 3. These droplets will create more entrained air relative to their diameter during their time of flight, because they have a larger surface to volume ratio. When these smaller droplets near the eye, they have an insufficient momentum to overcome the entrained air effect described above, and consequently are often deflected. Small droplets also have a shorter stopping distance. This factor contributes to their rapid deceleration before they reach the target. An evaporation rate is also higher for the droplets at the 17 microns diameter threshold. A higher evaporation rate helps to compound the problems of stopping distance, air entrainment, and momentum to drag force ratio.

Droplet diameters and mass deposition rates are measured at various distances. Droplets with diameter greater than or equal to 32 microns have a noticeably higher percentage of mass deposited. Particles with diameters less than or equal to 17 microns appear did not deposit significant mass over a wide range of distances. Droplets with diameters greater than or equal to 32 microns perform deposited mass at higher levels seem for diameters equal or less than 17 microns. See, for example,FIGS. 29Aand B.

In an implementation, a hand-held, portable ophthalmic dispenser typically is held about 3 cm from the eye as it creates fluid microspheres or micro droplets that travel to the eye of the user. Microspheres of the drug are formed and launched as a piezo material vibrates an ejection plate on the dispenser in a precise pattern of frequency and duration. A piezo material changes shape as a voltage is applied across it. A shape change is mechanically linked to vibrate the ejection plate. Size and velocity of the microspheres is critical so that spheres are not too small and slow moving that they fail to ready the eye. Similarly, quantities and mass of the spheres is important to maintain a correct dosage of drugs to the eye. Ejection plates are created by precise micro fabrication techniques. Microsphere diameter is related to diameter of holes in the ejection plate. Ejection plates will typically have hundreds of holes in the plate, all fabricated to have the same diameter with a nominal diameter typically between 15 microns and 60 microns.

In one implementation, the size of the microspheres ejected from such a plate will vary in volume according to the magnitude of plate motion. The frequency of the plate motion is determined by the frequency of an electrical voltage (typically a square wave) that actuates the piezo actuator attached to the ejector plate. Typically, the actuating voltage will be in the range of 100 kHz to 150 kHz and will have a duration of 10 milliseconds to 100 milliseconds per dose.

In one implementation, drug volume per dose is calculated from the diameter of the ejected spheres, number of holes in the plate, frequency of vibration, number of voltage cycles per ejection per hole, and length of time the plate is vibrated. For example, an ejection plate having 1000 holes that are 20 microns in diameter may eject spheres about 40 microns in diameter. If a sphere ejects from each hole about once per ten cycles then a 100 kHz vibration from the piezo will eject about 100,000/10 spheres per hole per second or about 10,000,000 spheres per second from all 1000 holes. If each sphere is 40 microns in diameter, then the ejector plate will dispense about 10,000,000*4/3*pi*((40e-6)/2)^3 cubic meters per second or about 10,000,000*4/3*pi*((40e-3)/2)^3=334 microliters per second. If the plate is actuated for 40 milliseconds, then about 13 microliters of drug are ejected.

While not to be limited by them, sphere size and velocity are related to the magnitude and frequency of the voltage applied to the piezo. In part, this is because magnitude of the ejector plate motion and piezo motion is related to frequency of the driving signal. Magnitude of the piezo motion is directly related to the voltage of the applied voltage. Ejection velocity is also dependent on the frequency and magnitude of the applied voltage. It has been found that the spheres are not ejected except in a fairly narrow range of frequency band with optimums for maximum speed and volume. Unfortunately, variation in manufacture of piezos causes this optimum to vary about 10% among a batch of piezos. This variation results in each dispense unit needing a slightly different voltage frequency to achieve the same dispense velocity and volume. Thus, each unit must be tuned during manufacture for a specific frequency. Typically, frequency rather than voltage is tuned due to the increase in circuit complexity and cost associated with having voltage control. On the other hand, control of the frequency of a square wave is accomplished by changing the frequency of the internal square wave generator (typically a microprocessor or FPGA).

In one implementation, in a portable device, voltage and power applied to the piezo is limited by breakdown voltages of electrical components and total battery energy. Thus, tuning for optimum ejection of spheres is required to achieve good ejection with minimum and maximum voltages. Tuning frequency slightly off the optimum allows control of the velocity of ejection for a given applied voltage. Similarly, total mass ejected per dose is controlled by the duration of ejection. Thus, a final tuning of driving frequency and driving time is needed to set ejection velocity and dose volume.

In one implementation, described here is a device and method for tuning the ejection velocity and dose size for a portable ophthalmic dispenser.

In one implementation, a small target plate with an associated weighing mechanism and a vision system that observes the region between the dispenser and target plate and a test fixture controller that initiates dispenses from the dispenser, receives the weight and velocity of the dispensed dose and calculated appropriate modifications to dispense constants in the ophthalmic delivery device. An ophthalmic dispenser has an externally programmable, internal controller with static memory (like EEPROM) to receive and store these constants.

In one implementation, the vision system will measure the velocity of the dispense. Typical dispense velocities are in the range of 0.5 to 5 meters per second or times to transit 5 cm of 10 to 100 milliseconds. Thus, a camera with a frame rate faster than 100 frames per second and ideally about 1000 frames per second would measure the leading edge of a dispense as it travels from the dispenser to the weighing station. Obviously, accuracy of measuring the front edge of the droplets depends upon an effective illumination source that is part of the vision system.

In one implementation, a dispenser will be placed in the tuning station in a rigid jig (or brought to the test area in a jig) with electrical connections to the dispenser. A dose will be dispensed toward the target about 3 cm away as the vision system measures the velocity of the front edge of the ejected droplets. Then, the target will be weighed. The controller then calculates the dispense volume and velocity. Typically, dispenses will be done at multiple frequencies to determine the optimal dispense frequency for correct droplet velocity. Dosage per dispense will be measured by the weighting system at this frequency and then dispense time will be set to a value that gives the correct dosage.

In one implementation, the dispense target approximates the area of an eye. At appropriate times, the dispense fluid is cleaned from the target with a blast of air followed by another weighing to tare the system. For accurate dose measurement, multiple dispenses may be done to increase the total mass measured.

In one implementation, a vision system can be used to verify the width of the dispense plume and even infer droplet size according to the degree to which the droplets are carried around the target by the airflow. This data can be collected in one or two directions (for example, from above or from the side) to verify aim of the dispense plate if needed. Similarly, a vision system that observes droplet flight from the side can infer dispense velocity and droplet size form the amount that the dispense falls below the target. With higher dispense velocities, the vertical position of the droplets will change less.

In one implementation, in order for this system to work, each portable device must have an externally programmable memory to hold the calibration constants for piezo frequency and duration. Additionally, for consumer and particularly prescription applications, each unit must be able to store the number of doses it is allowed to dispense. This is necessary because each unit will have to be slightly overfilled both to allow for calibration sprays and cleaning sprays which may occur each time the unit is opened. Furthermore, by the nature of a multi-hole ejector, it is necessary to have the entire ejector plate wetted for a full-dose dispense. The full wetting requirement will require that excess drug will have to be stored in the dispenser so that at the end of user dosing, there will be drug left in the dispenser.

In one implementation, the number of doses ejected can be restricted both for the consumer to prevent partial doses being used and for the supplier of the device so that per dose is accurately accomplished. For example, if a unit was 20% overfilled, then the consumer might buy 20% fewer units on an annual basis in the case of long-term use of the device.

In one implementation, along with calibration constants and dose limits, the memory may be programmable to allow the same unit to dispense different sized doses in the case where a smaller person or child should receive smaller doses of the drug. Similarly, in cases where the unit should alert the user if a dose is overdue, as in the case of a glaucoma medication where regular application of the drug is key to minimizing damage by the disease medication intervals and even an internal clock might be set. For example, during the day, doses might be required every 4 hours, but no doses are required from 9 pm to 6 am when the person is sleeping.

In one implementation, at the point of calibration of the dispense system, or later during packaging or prescription sales, the user constants might be downloaded to the device.

Although the foregoing describes various embodiments by way of illustration and example, the skilled artisan will appreciate that various changes and modifications may be practiced within the spirit and scope of the present application.

U.S. application Ser. No. 13/184,446, filed concurrently herewith, entitled “Ophthalmic Drug Delivery” and U.S. application Ser. No. 13/184,468, filed concurrently herewith, entitled “Method and System for Performing Remote Treatment and Monitoring” are also each herein incorporated by reference in their entireties.